172 related articles for article (PubMed ID: 11160713)
1. Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen.
Hammond AL; Plemper RK; Zhang J; Schneider U; Russell SJ; Cattaneo R
J Virol; 2001 Mar; 75(5):2087-96. PubMed ID: 11160713
[TBL] [Abstract][Full Text] [Related]
2. Recombinant measles viruses efficiently entering cells through targeted receptors.
Schneider U; Bullough F; Vongpunsawad S; Russell SJ; Cattaneo R
J Virol; 2000 Nov; 74(21):9928-36. PubMed ID: 11024120
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional studies of the measles virus hemagglutinin: identification of a novel site required for CD46 interaction.
Patterson JB; Scheiflinger F; Manchester M; Yilma T; Oldstone MB
Virology; 1999 Mar; 256(1):142-51. PubMed ID: 10087234
[TBL] [Abstract][Full Text] [Related]
4. Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently.
Tahara M; Takeda M; Seki F; Hashiguchi T; Yanagi Y
J Virol; 2007 Mar; 81(6):2564-72. PubMed ID: 17182683
[TBL] [Abstract][Full Text] [Related]
5. Cell-to-cell contact via measles virus haemagglutinin-CD46 interaction triggers CD46 downregulation.
Krantic S; Gimenez C; Rabourdin-Combe C
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2793-800. PubMed ID: 7595386
[TBL] [Abstract][Full Text] [Related]
6. Functional and structural interactions between measles virus hemagglutinin and CD46.
Nussbaum O; Broder CC; Moss B; Stern LB; Rozenblatt S; Berger EA
J Virol; 1995 Jun; 69(6):3341-9. PubMed ID: 7745681
[TBL] [Abstract][Full Text] [Related]
7. Efficient major histocompatibility complex class II-restricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cells.
Gerlier D; Trescol-Biémont MC; Varior-Krishnan G; Naniche D; Fugier-Vivier I; Rabourdin-Combe C
J Exp Med; 1994 Jan; 179(1):353-8. PubMed ID: 8270880
[TBL] [Abstract][Full Text] [Related]
8. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
[TBL] [Abstract][Full Text] [Related]
9. Functional modulation of human macrophages through CD46 (measles virus receptor): production of IL-12 p40 and nitric oxide in association with recruitment of protein-tyrosine phosphatase SHP-1 to CD46.
Kurita-Taniguchi M; Fukui A; Hazeki K; Hirano A; Tsuji S; Matsumoto M; Watanabe M; Ueda S; Seya T
J Immunol; 2000 Nov; 165(9):5143-52. PubMed ID: 11046046
[TBL] [Abstract][Full Text] [Related]
10. Use of site-specific mutagenesis and monoclonal antibodies to map regions of CD46 that interact with measles virus H protein.
Hsu EC; Sabatinos S; Hoedemaeker FJ; Rose DR; Richardson CD
Virology; 1999 Jun; 258(2):314-26. PubMed ID: 10366568
[TBL] [Abstract][Full Text] [Related]
11. Amino acid substitutions at position 481 differently affect the ability of the measles virus hemagglutinin to induce cell fusion in monkey and marmoset cells co-expressing the fusion protein.
Xie M; Tanaka K; Ono N; Minagawa H; Yanagi Y
Arch Virol; 1999; 144(9):1689-99. PubMed ID: 10542019
[TBL] [Abstract][Full Text] [Related]
12. The hemagglutinin of recent measles virus isolates induces cell fusion in a marmoset cell line, but not in other CD46-positive human and monkey cell lines, when expressed together with the F protein.
Tanaka K; Xie M; Yanagi Y
Arch Virol; 1998; 143(2):213-25. PubMed ID: 9541608
[TBL] [Abstract][Full Text] [Related]
13. Interactions between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry.
Devaux P; Loveland B; Christiansen D; Milland J; Gerlier D
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1477-81. PubMed ID: 8757989
[TBL] [Abstract][Full Text] [Related]
14. A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells.
Hsu EC; Sarangi F; Iorio C; Sidhu MS; Udem SA; Dillehay DL; Xu W; Rota PA; Bellini WJ; Richardson CD
J Virol; 1998 Apr; 72(4):2905-16. PubMed ID: 9525611
[TBL] [Abstract][Full Text] [Related]
15. Glycosyl-phosphatidylinositol-anchored and transmembrane forms of CD46 display similar measles virus receptor properties: virus binding, fusion, and replication; down-regulation by hemagglutinin; and virus uptake and endocytosis for antigen presentation by major histocompatibility complex class II molecules.
Varior-Krishnan G; Trescol-Biémont MC; Naniche D; Rabourdin-Combe C; Gerlier D
J Virol; 1994 Dec; 68(12):7891-9. PubMed ID: 7966579
[TBL] [Abstract][Full Text] [Related]
16. Wild-type measles virus with the hemagglutinin protein of the edmonston vaccine strain retains wild-type tropism in macaques.
Takeuchi K; Nagata N; Kato SI; Ami Y; Suzaki Y; Suzuki T; Sato Y; Tsunetsugu-Yokota Y; Mori K; Van Nguyen N; Kimura H; Nagata K
J Virol; 2012 Mar; 86(6):3027-37. PubMed ID: 22238320
[TBL] [Abstract][Full Text] [Related]
17. Altered interaction of the matrix protein with the cytoplasmic tail of hemagglutinin modulates measles virus growth by affecting virus assembly and cell-cell fusion.
Tahara M; Takeda M; Yanagi Y
J Virol; 2007 Jul; 81(13):6827-36. PubMed ID: 17442724
[TBL] [Abstract][Full Text] [Related]
18. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains.
Schneider-Schaulies J; Schnorr JJ; Brinckmann U; Dunster LM; Baczko K; Liebert UG; Schneider-Schaulies S; ter Meulen V
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3943-7. PubMed ID: 7732009
[TBL] [Abstract][Full Text] [Related]
19. Targeted measles virus vector displaying echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regression.
Hallak LK; Merchan JR; Storgard CM; Loftus JC; Russell SJ
Cancer Res; 2005 Jun; 65(12):5292-300. PubMed ID: 15958576
[TBL] [Abstract][Full Text] [Related]
20. Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells.
Schneider-Schaulies J; Schnorr JJ; Schlender J; Dunster LM; Schneider-Schaulies S; ter Meulen V
J Virol; 1996 Jan; 70(1):255-63. PubMed ID: 8523534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
